Relapsed follicular lymphoma sequentially treated with ritusimab and 90-Y-ibritumomab tiuxetan
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F07%3A00004014" target="_blank" >RIV/61989592:15110/07:00004014 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Relapsed follicular lymphoma sequentially treated with ritusimab and 90-Y-ibritumomab tiuxetan
Original language description
Monoclonal antibodies have dramatically changed the treatment possibilities for follicular lymphoma. 90Y-ibritumomab tiuxetan (Zevalin?) is the first radioimmunotherapy agent approved for the treatment of relapsed and resistant follicular lymphoma patients. Long-term benefi t was observed especially for patients achieving CR after radioimmunotherapy.
Czech name
Recidivující folikulární lymfom následně léčený ritusimabem a 90-Y-ibritumomab tiuxetanem.
Czech description
Monoklonální protilátky dramaticky změnily možnosti léčby folikulárního lymfomu. 90Y-ibritumomab tiuxetan (Zevalin?) je první radioimunologický prostředek schválený pro léčbu pacientů s recidivujícím a rezistentním folikulárním lymfomem.
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/NR9502" target="_blank" >NR9502: Integrated 2-[fluorine-18] fluoro-2-deoxy-D-glucose positron emission tomography with computer tomography as basic imaging method for the evaluation of non-Hodgkin´s lymphoma patients</a><br>
Continuities
Z - Vyzkumny zamer (s odkazem do CEZ)
Others
Publication year
2007
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Biomedical Papers
ISSN
1213-8118
e-ISSN
—
Volume of the periodical
151
Issue of the periodical within the volume
1
Country of publishing house
CZ - CZECH REPUBLIC
Number of pages
4
Pages from-to
109-112
UT code for WoS article
—
EID of the result in the Scopus database
—